Companies: 10,795·Total market cap: $144.5T
Mural Oncology plc

Mural Oncology plc

MURANASDAQHealthcare
$2.04
+$0.00(+0.00%)
Market Cap$35382751
P/E Ratio
52W High$4.74
52W Low$0.95
Overview

Mural Oncology plc(MURA)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MURA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-6.93mura eps ttm · mura earnings per shareEarnings history
PE Ratio (TTM)mura pe ratio ttm · mura price to earningsPE Ratio deep dive
Revenue (TTM)0.00mura revenue ttm · mura annual revenueFull revenue history
Dividend Yield不分红does mura pay dividends · mura dividend yieldDividend history
Shares Outstanding17.0Mmura shares outstanding · mura floatShares outstanding history
Next EarningsTBAmura earnings date · mura next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$0.00
202220232024
mural oncology plc revenue · mura revenue 2024
FY 2024Net Income-$128.5M▲ +38.05% YoY
202220232024
mural oncology plc net income · mura profit 2024
FY 2024EPS$-7.58▲ +39.02% YoY
202220232024
mura eps · mural oncology plc earnings per share 2024
TTM:Revenue: $0.00Net Income: -$119.1MEPS: $-6.93View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy2 位分析师is mura a buy · mura analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$2.04Current
$Avg Target
$High
mura price target · mura 12 month forecast

合计: 2 · 买入占比: 50.0%

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M-1.92%
YTD+0.00%
1Y-44.11%
5Y-46.32%

关于 Mural Oncology plc

CEOCaroline J. Loew
IPO DateNov 16, 2023
Employees116
CountryIE

Mural Oncology plc a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is current…

what is mural oncology plc · mura stock overview · mural oncology plc company profile · who is mural oncology plc ceo · mura NASDAQ · mural oncology plc headquarters · mural oncology plc business segments

关于股票概览与关键数据

Mural Oncology plc(MURA)是 Biotechnology 行业的 Healthcare 类公司,于 Nov 16, 2023 在 NASDAQ 上市。截至最近交易日,MURA 股价为 $2.04,市值约为 $35.4M。过去12个月累计回报 -44.11%,年初至今回报 +0.00%。

根据 2 位华尔街分析师,Mural Oncology plc 股票共识评级为Buy,12个月平均目标价为 $—。2024 财年 Mural Oncology plc 营收 —,净利润 -$128.5M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Mural Oncology plc(MURA)股价为 $2.04,在 NASDAQ 上市,52周区间为 $0.95 – $4.74。

MURA 最新股价MURA quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议